HPLC column NUCLEODUR ® C 8 Gravity, 5 µm, 150 mm, 4.6 mm
Order number: 1HLC.1
Part number: AC100007173
£ 696.60*
*Prices plus VAT plus shipping costs£ 835.92*
*incl. VAT, plus shipping costsPrice Breakdown
1
6
24
Developed to align with modern chemical standards, the Hplc Column Nucleodur ® C 8 Gravity, 5 μm, 150 mm, 4.6 mm offers exceptional performance for liquid chromatography (LC, HPLC). Its reversed phase (RP) design, featuring a high density C 8 phase based on high purity NUCLEODUR ® silica gel, ensures efficient separation of basic and other ionizable analytes. The endcapped nature of this column suppresses unwanted polar interactions, making it ideal for RP applications and valuable for method development. With a particle size of 5 μm, a specific surface area of 340 m²/g, and a pH stability range of 1-11, this column exhibits excellent pressure stability up to 600 bar and temperature stability up to 60°C. Recomm
- Category: Separation columns for HPLC
- Specific surface according to BET: 340 m²/g
- Phase: C 8 Gravity
- Column volume: 2.5 ml
- Application Database (Macherey-Nagel): HPLC
- Column type: HPLC column
- USP listing: L7
- Interactions / retention mechanism: hydrophobic (van der Waals)
- Particle size: 5 µm
- pH stability: 1,0-11,0
- Endcapped: yes
- Temperature stability: 60 ° C
- Pore volume: 0.9 ml/g
- Pore size: 110 Å
- Column shape: Analytical separation column
- Eluent in column: Acetonitrile - Water
- Surface chemistry: Base deactivated (BDS), High density monomeric octyl (C 8 , MOS) modification
- Pressure stability: 600 bar
- Particle type: Fully porous particles (FPP)
- Similar phases: NUCLEOSIL ® C 8 HD Xterra ® RP 8 / MS C 8 Luna ® C 8 Zorbax ® Eclipse XDB-C 8
- L x Ø internal (column): 150 x 4.6 mm
- Separation principle: Reversed phase (RP)
- Recommended application(s): In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals
| Name | Value | |
|---|---|---|
| Phase | : | C 8 Gravity |
| Endcapped | : | yes |
| Pore size | : | 110 Å |
| Column type | : | HPLC column |
| Pore volume | : | 0.9 ml/g |
| USP listing | : | L7 |
| Column shape | : | Analytical separation column |
| pH stability | : | 1,0-11,0 |
| Column volume | : | 2.5 ml |
| Particle size | : | 5 µm |
| Particle type | : | Fully porous particles (FPP) |
| Similar phases | : | NUCLEOSIL ® C 8 HD Xterra ® RP 8 / MS C 8 Luna ® C 8 Zorbax ® Eclipse XDB-C 8 |
| Eluent in column | : | Acetonitrile - Water |
| Surface chemistry | : | Base deactivated (BDS), High density monomeric octyl (C 8 , MOS) modification |
| Pressure stability | : | 600 bar |
| Separation principle | : | Reversed phase (RP) |
| Temperature stability | : | 60 ° C |
| L x Ø internal (column) | : | 150 x 4.6 mm |
| Recommended application(s) | : | In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals |
| Specific surface according to BET | : | 340 m²/g |
| Interactions / retention mechanism | : | hydrophobic (van der Waals) |
| Application Database (Macherey-Nagel) | : | HPLC |
